Coming Soon

Diosynvax LTD.

Registration Number 10860446

Trading name: Dios Vax

Dios Vax develops innovative vaccine technologies and therapeutics, focusing on the creation of advanced solutions to improve public health and combat infectious diseases.

Company Overview

Company Name
Diosynvax LTD.
Registration Number
10860446
Founded
11 July 2017
Age
8 years
Industry Region
East of England
Registered Postcode
SG14 1QN

Online Profile

Special Flags

Public Funding Received

Public Funding for Diosynvax LTD.

2023-10-01
Clinical development of DIOS-HFVac3: A pre-clinically effective multivalent vaccine for Lassa fever virus, Marburg virus, and Sudan ebolavirus
Small Business Research Initiative
2022-04-01
HFVac4: A Quadrivalent Viral Haemorrhagic Fever Vaccine for Africa
Small Business Research Initiative
2021-12-01
DIOS-CoVax clinical trial recruitment and analysis
Collaborative R&D
2020-09-01
DIOS-CoVax - A vaccine designed to protect against COVID-19 and future Coronavirus epidemics, mitigating antibody enhanced disease.
Collaborative R&D
2020-06-01
Digital Immune Optimized and Selected Pan-Influenza Vaccine Antigens ‘DIOS-PIVa’
Feasibility Studies
2019-04-01
Digital Immune Optimized and Selected Pan-Influenza Vaccine Antigens (DIOS-PIVa)
Feasibility Studies

Get notified when we’re launching.

Want fast, powerful sales prospecting for UK companies? Signup below to find out when we're live.